- Investing Ideas
- U.S. Healthcare Undervalued based on future growth
U.S. Healthcare Undervalued based on future growth
Results
7
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
7 companies
CONMED
Market Cap: US$1.3b
A medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.
CNMD
US$41.27
7D
-8.3%
1Y
-16.7%
Nutex Health
Market Cap: US$1.2b
Operates as a healthcare services and operations company in the United States.
NUTX
US$157.21
7D
-10.7%
1Y
69.2%
GMR Solutions
Market Cap: US$994.7m
Operates as a provider of emergency medical services (EMS), essential alternate-site, out-of-hospital care, and mobile clinical practice groups in United States.
GMRS
US$12.65
7D
-6.4%
1Y
n/a
Auna
Market Cap: US$377.5m
A healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia.
AUNA
US$5.02
7D
-0.6%
1Y
-20.9%
OptimizeRx
Market Cap: US$121.2m
Operates as a digital healthcare technology company.
OPRX
US$6.21
7D
-6.6%
1Y
-55.5%
CareCloud
Market Cap: US$94.8m
A healthcare information technology company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States.
CCLD
US$2.19
7D
-6.6%
1Y
-11.3%
Xtant Medical Holdings
Market Cap: US$60.5m
Provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally.
XTNT
US$0.43
7D
-2.9%
1Y
-33.5%